In order to validate the relevance of our findings in human disease, and to test whether CSF-1 depletion could potentially be used for the prevention or treatment of brain metastasis, we examined the expression of the growth factors CSF-1 and IL-34 and the corresponding receptor CSF-1R in brain metastases of cancer patients. Here, IL34 is linked to cancer.